Furthermore, injection with 10 μg dimeric BsAb (EphA10/CD3) produced tumor inhibition just as potent as that of anti-EphA10 IgG (Fig 5B) and dimeric BsAb (His/CD3) had no effect (Fig 5C). The gene discussed is EPHA10; the disease is neoplasm.